Related Experiment Videos

Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus

Y Sumita1, M Fukasawa, T Okuda

  • 1Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.

Antimicrobial Agents and Chemotherapy
|March 1, 1990
PubMed

Insights

SM-7338, a carbapenem antibiotic, binds strongly to Staphylococcus aureus penicillin-binding proteins 1, 2, and 4. Its binding to PBP 3 is transient, with rapid release observed, impacting its efficacy.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Staphylococcus aureus is a significant human pathogen.
  • Carbapenem antibiotics are crucial for treating severe bacterial infections.
  • Understanding antibiotic-protein interactions is key to developing new drugs.

Purpose of the Study:

  • To investigate the binding affinities of SM-7338 to Staphylococcus aureus penicillin-binding proteins (PBPs).
  • To characterize the interaction dynamics between SM-7338 and PBP 3.

Main Methods:

  • Competition assays using [14C]benzylpenicillin to determine PBP affinities.
  • Saturation binding assays with [14C]SM-7338 to evaluate binding kinetics.
  • Measurement of SM-7338 release from PBP 3-SM-7338 complexes.

Main Results:

  • SM-7338 exhibited high affinity for PBPs 1, 2, and 4 of Staphylococcus aureus.
  • Binding to PBP 3 was observed but showed saturation at 1 microgram/ml.
  • Rapid dissociation of SM-7338 from PBP 3 was confirmed, with a half-life of 2 minutes.

Conclusions:

  • SM-7338 demonstrates differential binding affinities to Staphylococcus aureus PBPs.
  • The transient interaction with PBP 3 may influence the overall antibacterial activity of SM-7338.
  • Further studies are warranted to elucidate the clinical implications of these binding characteristics.

Related Concept Videos